272 related articles for article (PubMed ID: 35632742)
1. A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using
King RE; Bilger A; Rademacher J; Ward-Shaw ET; Hu R; Lambert PF; Thibeault SL
Viruses; 2022 May; 14(5):. PubMed ID: 35632742
[TBL] [Abstract][Full Text] [Related]
2. Expanded Basal Compartment and Disrupted Barrier in Vocal Fold Epithelium Infected with Mouse Papillomavirus MmuPV1.
King RE; Ward-Shaw ET; Hu R; Lambert PF; Thibeault SL
Viruses; 2022 May; 14(5):. PubMed ID: 35632798
[TBL] [Abstract][Full Text] [Related]
3. The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.
King RE; Rademacher J; Ward-Shaw ET; Hu R; Bilger A; Blaine-Sauer S; Spurgeon ME; Thibeault SL; Lambert PF
Laryngoscope; 2024 May; 134(5):2322-2330. PubMed ID: 38084790
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Models of Laryngeal Papillomavirus Infection: A Scoping Review.
King RE; Bilger A; Rademacher J; Lambert PF; Thibeault SL
Laryngoscope; 2023 Dec; 133(12):3256-3268. PubMed ID: 37227124
[TBL] [Abstract][Full Text] [Related]
5. Key aspects of papillomavirus infection influence the host cervicovaginal microbiome in a preclinical murine papillomavirus (MmuPV1) infection model.
Spurgeon ME; Townsend EC; Blaine-Sauer S; McGregor SM; Horswill M; den Boon JA; Ahlquist P; Kalan L; Lambert PF
mBio; 2024 Jun; 15(6):e0093324. PubMed ID: 38742830
[TBL] [Abstract][Full Text] [Related]
6. MmuPV1 E7's interaction with PTPN14 delays Epithelial differentiation and contributes to virus-induced skin disease.
Romero-Masters JC; Grace M; Lee D; Lei J; DePamphilis M; Buehler D; Hu R; Ward-Shaw E; Blaine-Sauer S; Lavoie N; White EA; Munger K; Lambert PF
PLoS Pathog; 2023 Apr; 19(4):e1011215. PubMed ID: 37036883
[TBL] [Abstract][Full Text] [Related]
7. A Novel
Spurgeon ME; Uberoi A; McGregor SM; Wei T; Ward-Shaw E; Lambert PF
mBio; 2019 Mar; 10(2):. PubMed ID: 30837335
[TBL] [Abstract][Full Text] [Related]
8. A Novel Model for Papillomavirus-Mediated Anal Disease and Cancer Using the Mouse Papillomavirus.
Blaine-Sauer S; Shin MK; Matkowskyj KA; Ward-Shaw E; Lambert PF
mBio; 2021 Aug; 12(4):e0161121. PubMed ID: 34281391
[TBL] [Abstract][Full Text] [Related]
9. A novel lineage-tracing mouse model for studying early MmuPV1 infections.
Yilmaz V; Louca P; Potamiti L; Panayiotidis M; Strati K
Elife; 2022 May; 11():. PubMed ID: 35533001
[TBL] [Abstract][Full Text] [Related]
10. Role of E6 in Maintaining the Basal Cell Reservoir during Productive Papillomavirus Infection.
Saunders-Wood T; Egawa N; Zheng K; Giaretta A; Griffin HM; Doorbar J
J Virol; 2022 Mar; 96(5):e0118121. PubMed ID: 35019722
[TBL] [Abstract][Full Text] [Related]
11. An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer.
Wei T; Buehler D; Ward-Shaw E; Lambert PF
mBio; 2020 May; 11(3):. PubMed ID: 32398315
[TBL] [Abstract][Full Text] [Related]
12. The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues.
Xue XY; Majerciak V; Uberoi A; Kim BH; Gotte D; Chen X; Cam M; Lambert PF; Zheng ZM
PLoS Pathog; 2017 Nov; 13(11):e1006715. PubMed ID: 29176795
[TBL] [Abstract][Full Text] [Related]
13. Mus musculus papillomavirus 1 is a key driver of skin cancer development upon immunosuppression.
Dorfer S; Strasser K; Schröckenfuchs G; Bonelli M; Bauer W; Kittler H; Cataisson C; Fischer MB; Lichtenberger BM; Handisurya A
Am J Transplant; 2021 Feb; 21(2):525-539. PubMed ID: 33063442
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.
Jiang RT; Wang JW; Peng S; Huang TC; Wang C; Cannella F; Chang YN; Viscidi RP; Best SRA; Hung CF; Roden RBS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515303
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical implications of low-risk human papillomavirus among patients with recurrent respiratory papillomatosis in Rio de Janeiro, Brazil.
Figueiredo MC; Justino MC; Delmonico L; Silvestre RT; de Castro TL; Dos Santos Moreira A; Macedo JMB; da Costa Carvalho MDG; Scherrer L; de Medeiros Lima DJM; Alves G; Ornellas MH
Auris Nasus Larynx; 2019 Aug; 46(4):570-575. PubMed ID: 30581074
[TBL] [Abstract][Full Text] [Related]
16. Laryngeal distribution of recurrent respiratory papillomatosis in a previously untreated cohort.
Benedict PA; Ruiz R; Yoo M; Verma A; Ahmed OH; Wang B; Dion GR; Voigt A; Merati A; Rosen CA; Amin MR; Branski RC
Laryngoscope; 2018 Jan; 128(1):138-143. PubMed ID: 28714564
[TBL] [Abstract][Full Text] [Related]
17. Deficiency in
Torres AD; King RE; Uberoi A; Buehler D; Yoshida S; Ward-Shaw E; Lambert PF
J Virol; 2024 Jun; ():e0017424. PubMed ID: 38869286
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Topically Administered Dihydroartemisinin in Treating Papillomavirus-Induced Anogenital Dysplasia in Preclinical Mouse Models.
Gunder LC; Blaine-Sauer S; Johnson HR; Shin MK; Auyeung AS; Zhang W; Leverson GE; Ward-Shaw ET; King RE; McGregor SM; Matkowskyj KA; Lambert PF; Carchman EH
Viruses; 2022 Jul; 14(8):. PubMed ID: 35893697
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated with Iatrogenic Laryngeal Injury in Recurrent Respiratory Papillomatosis.
So RJ; Hillel AT; Motz KM; Akst LM; Best SR
Otolaryngol Head Neck Surg; 2024 Apr; 170(4):1091-1098. PubMed ID: 38123898
[TBL] [Abstract][Full Text] [Related]
20. Sexual transmission of murine papillomavirus (MmuPV1) in
Spurgeon ME; Lambert PF
Elife; 2019 Oct; 8():. PubMed ID: 31621578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
